Development and validation of FinTox: A new screening tool to assess cancer-related financial toxicity.

FinTox's robust psychometric properties and diagnostic accuracy position it as a reliable tool for detecting financial toxicity. Future research should evaluate its responsiveness to changes over time and integration into clinical workflows.